My Quote Request
No products added yet
6505-01-388-4561
20 Products
OPTIRAY 240
IOVERSOL INJECTION
NSN, MFG P/N
6505013884561
NSN
6505-01-388-4561
MFG
MALLINCKRODT INTL
Description
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 509 MG/ML IOVERSOL CONTENT; 240 MG/ML IODINE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00019-1324-21
IOVERSOL INJECTION
NSN, MFG P/N
6505013884561
NSN
6505-01-388-4561
MFG
MALLINCKRODT INTL
Description
PRIMARY CONTAINER CONTENT QUANTITY: 200.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 509 MG/ML IOVERSOL CONTENT; 240 MG/ML IODINE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
AL2700
WATER FOR INHALATION,STERILE,USP
NSN, MFG P/N
6505013885011
NSN
6505-01-388-5011
AL2700
WATER FOR INHALATION,STERILE,USP
NSN, MFG P/N
6505013885011
NSN
6505-01-388-5011
MFG
AUTOMATIC LIQUID PACKAGING INC HEALTHCARE PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLILITERS WATER, PURIFIED ACTIVE INGREDIENT
ADMINISTRATION: INHALATION
PRIMARY CONTAINER CONTENT QUANTITY: 750.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, NEBULIZER
SPECIAL FEATURES: 12/PG; WITHOUT ADAPTER
Related Searches:
NDC00169-0070-11
INSULIN HUMAN INJECTION,USP
NSN, MFG P/N
6505013886338
NSN
6505-01-388-6338
NDC00169-0070-11
INSULIN HUMAN INJECTION,USP
NSN, MFG P/N
6505013886338
NSN
6505-01-388-6338
MFG
NOVO NORDISK INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 INTERNATIONAL UNITS INSULIN, HUMAN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN HUMAN INJECTION USP 100IU/ML 10ML VIAL
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, NOVO-NORDISK
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: SEMI-SYNTHETIC HUMAN INSULIN; RECOMBINANT DNA ORIGIN
Related Searches:
NDC00169-0111-01
INSULIN HUMAN INJECTION,USP
NSN, MFG P/N
6505013886338
NSN
6505-01-388-6338
NDC00169-0111-01
INSULIN HUMAN INJECTION,USP
NSN, MFG P/N
6505013886338
NSN
6505-01-388-6338
MFG
NOVO NORDISK INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 INTERNATIONAL UNITS INSULIN, HUMAN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN HUMAN INJECTION USP 100IU/ML 10ML VIAL
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, NOVO-NORDISK
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: SEMI-SYNTHETIC HUMAN INSULIN; RECOMBINANT DNA ORIGIN
Related Searches:
VELOSULIN
INSULIN HUMAN INJECTION,USP
NSN, MFG P/N
6505013886338
NSN
6505-01-388-6338
VELOSULIN
INSULIN HUMAN INJECTION,USP
NSN, MFG P/N
6505013886338
NSN
6505-01-388-6338
MFG
NOVO NORDISK INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 INTERNATIONAL UNITS INSULIN, HUMAN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN HUMAN INJECTION USP 100IU/ML 10ML VIAL
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, NOVO-NORDISK
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: SEMI-SYNTHETIC HUMAN INSULIN; RECOMBINANT DNA ORIGIN
Related Searches:
VELOSULIN HUMAN
INSULIN HUMAN INJECTION,USP
NSN, MFG P/N
6505013886338
NSN
6505-01-388-6338
VELOSULIN HUMAN
INSULIN HUMAN INJECTION,USP
NSN, MFG P/N
6505013886338
NSN
6505-01-388-6338
MFG
NOVO NORDISK INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 INTERNATIONAL UNITS INSULIN, HUMAN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN HUMAN INJECTION USP 100IU/ML 10ML VIAL
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, NOVO-NORDISK
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: SEMI-SYNTHETIC HUMAN INSULIN; RECOMBINANT DNA ORIGIN
Related Searches:
4497
ALLANTOIN GEL
NSN, MFG P/N
6505013887580
NSN
6505-01-388-7580
MFG
SMITH & NEPHEW INC. DBA SMITH AND NEPHEW WOUND AND MGT DIV WOUND MANAGEMENT
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/W ALLANTOIN ACTIVE INGREDIENT
ADMINISTRATION: WOUND SITE
PHARMACEUTICAL VEHICLE TYPE: GLYCERIN
PRIMARY CONTAINER CONTENT QUANTITY: 7.000 OUNCES
PRIMARY CONTAINER TYPE: CAN WITH PUMP DISPENSER
SPECIAL FEATURES: FOR TREATMENT OF WOUNDS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
4497-00
ALLANTOIN GEL
NSN, MFG P/N
6505013887580
NSN
6505-01-388-7580
MFG
SMITH & NEPHEW INC. DBA SMITH AND NEPHEW WOUND AND MGT DIV WOUND MANAGEMENT
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 PERCENTAGE, W/W ALLANTOIN ACTIVE INGREDIENT
ADMINISTRATION: WOUND SITE
PHARMACEUTICAL VEHICLE TYPE: GLYCERIN
PRIMARY CONTAINER CONTENT QUANTITY: 7.000 OUNCES
PRIMARY CONTAINER TYPE: CAN WITH PUMP DISPENSER
SPECIAL FEATURES: FOR TREATMENT OF WOUNDS
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00173-0467-00
SALMETEROL XINAFOAT
NSN, MFG P/N
6505013889515
NSN
6505-01-388-9515
MFG
GLAXO WELLCOME INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: SINGLE SIZE; THERAPEUTICALLY EQUIVALENT TO SEREVENT BY GLASO INC.; 60 DOSE INSTITUTIONAL PG
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SALMETEROL XINAFOATE INHALATION AEROSOL 60 DOSES
Related Searches:
SEREVENT
SALMETEROL XINAFOAT
NSN, MFG P/N
6505013889515
NSN
6505-01-388-9515
MFG
GLAXO WELLCOME INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: SINGLE SIZE; THERAPEUTICALLY EQUIVALENT TO SEREVENT BY GLASO INC.; 60 DOSE INSTITUTIONAL PG
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SALMETEROL XINAFOATE INHALATION AEROSOL 60 DOSES
Related Searches:
SEREVENT INHALATION AEROSOL
SALMETEROL XINAFOAT
NSN, MFG P/N
6505013889515
NSN
6505-01-388-9515
SEREVENT INHALATION AEROSOL
SALMETEROL XINAFOAT
NSN, MFG P/N
6505013889515
NSN
6505-01-388-9515
MFG
GLAXO WELLCOME INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: SINGLE SIZE; THERAPEUTICALLY EQUIVALENT TO SEREVENT BY GLASO INC.; 60 DOSE INSTITUTIONAL PG
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SALMETEROL XINAFOATE INHALATION AEROSOL 60 DOSES
Related Searches:
NDC00173-0465-00
SALMETEROL XINAFOAT
NSN, MFG P/N
6505013889527
NSN
6505-01-388-9527
MFG
GLAXO WELLCOME INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: SINGLE SIZE; THERAPEUTICALLY EQUIVALENT TO SEREVENT BY GLAXO IN.; 120 DOSE REFILL FOR NDC00173-0464-00
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SALMETEROL XINAFOATE INHALATION AEROSOL 120 DOSES
Related Searches:
SEREVENT
SALMETEROL XINAFOAT
NSN, MFG P/N
6505013889527
NSN
6505-01-388-9527
MFG
GLAXO WELLCOME INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: SINGLE SIZE; THERAPEUTICALLY EQUIVALENT TO SEREVENT BY GLAXO IN.; 120 DOSE REFILL FOR NDC00173-0464-00
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SALMETEROL XINAFOATE INHALATION AEROSOL 120 DOSES
Related Searches:
SEREVENT INHALATION AEROSOL
SALMETEROL XINAFOAT
NSN, MFG P/N
6505013889527
NSN
6505-01-388-9527
SEREVENT INHALATION AEROSOL
SALMETEROL XINAFOAT
NSN, MFG P/N
6505013889527
NSN
6505-01-388-9527
MFG
GLAXO WELLCOME INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: SINGLE SIZE; THERAPEUTICALLY EQUIVALENT TO SEREVENT BY GLAXO IN.; 120 DOSE REFILL FOR NDC00173-0464-00
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SALMETEROL XINAFOATE INHALATION AEROSOL 120 DOSES
Related Searches:
43856
MINERAL OIL,LANOLATED,WATER-DISPERSIBLE
NSN, MFG P/N
6505013892092
NSN
6505-01-389-2092
43856
MINERAL OIL,LANOLATED,WATER-DISPERSIBLE
NSN, MFG P/N
6505013892092
NSN
6505-01-389-2092
MFG
MOORE MEDICAL LLC
Description
PHARMACEUTICAL VEHICLE TYPE: MINERAL OIL
PRIMARY CONTAINER CONTENT QUANTITY: 3.500 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
Related Searches:
NDC57664-0872-18
NIFEDIPINE CAPSULES,USP
NSN, MFG P/N
6505013896000
NSN
6505-01-389-6000
NDC57664-0872-18
NIFEDIPINE CAPSULES,USP
NSN, MFG P/N
6505013896000
NSN
6505-01-389-6000
MFG
CARACO PHARMACEUTICAL LABORATORIES LTD.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS NIFEDIPINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NIFEDIPINE CAPSULES USP 10MG 1000S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ASTRAMORPH
MORPHINE SULFATE INJECTION,USP
NSN, MFG P/N
6505013896009
NSN
6505-01-389-6009
ASTRAMORPH
MORPHINE SULFATE INJECTION,USP
NSN, MFG P/N
6505013896009
NSN
6505-01-389-6009
MFG
APP PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS MORPHINE SULFATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MORPHINE SULFATE INJECTION USP 1MG/ML 2ML AMPUL 100S
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: CLASS 2
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC00186-1160-03
MORPHINE SULFATE INJECTION,USP
NSN, MFG P/N
6505013896009
NSN
6505-01-389-6009
NDC00186-1160-03
MORPHINE SULFATE INJECTION,USP
NSN, MFG P/N
6505013896009
NSN
6505-01-389-6009
MFG
APP PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS MORPHINE SULFATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MORPHINE SULFATE INJECTION USP 1MG/ML 2ML AMPUL 100S
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: CLASS 2
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC00078-0234-05
MILRINONE LACTATE INJECTION
NSN, MFG P/N
6505013898401
NSN
6505-01-389-8401
NDC00078-0234-05
MILRINONE LACTATE INJECTION
NSN, MFG P/N
6505013898401
NSN
6505-01-389-8401
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MILRINONE LACTATE INJECTION 10ML VIAL 10S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: EA ML CONTAINS MILVINONE LACTATE EQUIVALENT TO ONE MG MILVINONE
